J&J joins Bris­tol My­ers Squibb with $100M com­mit­ment to di­ver­si­ty ef­forts

A day af­ter the Bris­tol My­ers Squibb Foun­da­tion launched a $100 mil­lion pro­gram to di­ver­si­fy clin­i­cal tri­als, John­son & John­son says it’s al­so com­mit­ting $100 mil­lion to health eq­ui­ty ef­forts.

“There is an ur­gent need to take on the in­equities root­ed in sys­temic racism that threat­en health in com­mu­ni­ties of col­or across the Unit­ed States,” CEO Alex Gorsky said in a state­ment. “That’s why John­son & John­son is fo­cus­ing its ef­forts and com­mit­ting $100 mil­lion to ad­dress racial and so­cial in­jus­tice as the crit­i­cal pub­lic health is­sue that it is.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER